11/14/2025
The latest edition of PCORI's Emerging Health Care Innovation Brief highlights:
◼️ The first new idiopathic pulmonary fibrosis therapy in over a decade
◼️ FDA approval of an adjuvant treatment for adults with cutaneous squamous cell carcinoma at high risk of recurrence
Other topics to watch:
◼️ AMT-130, a gene therapy for Huntington disease
◼️ Bitopertin, a glycine transporter inhibitor for rare inherited diseases that affect heme synthesis
Learn more: https://pcori.me/3JMS1GE